Sooma raises $5.5m to expand access for neuromodulation device

Sooma’s tDCS system is a portable, patient-administered neuromodulation device that uses a mild electrical current to stimulate the brain and alleviate the symptoms of depression. Image Credit: 13_Phunkod / Shutterstock. Finland-based Sooma Medical has raised €5m ($5.5m) in venture funding to expand market access for its transcranial direct current stimulation (tDCS) device for at-home treatment […]
SetPoint wins second FDA breakthrough device nod for neurostim device

Patients with multiple sclerosis have damaged myelin sheath – a layer surrounding neurons that help insulate electrical activity. Image credit: Shutterstock/CC7. SetPoint Medical has a breakthrough device designation for its neuroimmune modulation device for the treatment of relapsing-remitting multiple sclerosis (RRMS). This is the second breakthrough designation granted to the company by the US Food […]
ICU Medical in mobile: Theme innovation strategy
ICU Medical grant share with mobile as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Disposable infusion fluid delivery device for programmable large volume drug delivery (Patent ID: US20230321340A1) The patent filed by ICU Medical Inc. describes […]
Becton Dickinson and Co in digitalization: Theme innovation strategy
Becton Dickinson and Co grant share with digitalization as a theme is 60% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Efficient storage of drug library editor entries (Patent ID: US20230420120A1) The patent filed by Becton Dickinson and Co. discloses systems […]
ICU Medical in future of work: Theme innovation strategy
ICU Medical grant share with future of work as a theme is 37% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Systems and methods for a graphical interface including a graphical representation of medical data (Patent ID: US20230325772A1) The patent filed […]
Becton Dickinson and Co in internet of things: Theme innovation strategy
Becton Dickinson and Co grant share with internet of things as a theme is 53% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Smart medication delivery devices for providing users with delivery infomatics and methods of using same (Patent ID: US20230372611A1) […]
ICU Medical in cybersecurity: Theme innovation strategy
ICU Medical grant share with cybersecurity as a theme is 25% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Passing authentication token to authorize access to rest calls via web sockets (Patent ID: US20230410989A1) The patent filed by ICU Medical Inc. […]
Sysmex in artificial intelligence: Theme innovation strategy
Sysmex grant share with artificial intelligence as a theme is 50% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Image analysis method, apparatus, program, and learned deep learning algorithm (Patent ID: US20230419696A1) The patent filed by Sysmex Corp. describes an image […]
ICU Medical in cloud: Theme innovation strategy
ICU Medical grant share with cloud as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Passing authentication token to authorize access to rest calls via web sockets (Patent ID: US20230410989A1) The patent filed by ICU Medical Inc. […]
Sysmex in future of work: Theme innovation strategy
Sysmex grant share with future of work as a theme is 35% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents. Recent Patents Application: Control method for test system, control method for smear preparation device, test system, and smear preparation device (Patent ID: US20230408381A1) The […]